Fatigue in advanced kidney disease
Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biologi...
Gespeichert in:
Veröffentlicht in: | Kidney international 2014-09, Vol.86 (3), p.497-505 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 505 |
---|---|
container_issue | 3 |
container_start_page | 497 |
container_title | Kidney international |
container_volume | 86 |
creator | Artom, Micol Moss-Morris, Rona Caskey, Fergus Chilcot, Joseph |
description | Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting. |
doi_str_mv | 10.1038/ki.2014.86 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1558516862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253815303318</els_id><sourcerecordid>1558516862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-8f56d093455d42920477308428c0265e57f48277746ed818f7e1259f0f986c853</originalsourceid><addsrcrecordid>eNpt0E9LwzAYx_EgipvTiy9Ail5E6HyS5knSowynwsCLnkNNnkr2p51NO9i7t3PqQTyFwIcfD1_GzjmMOWTmdhHGArgcG3XAhhxFlnKNeMiGAAZTgZkZsJMY59D_8wyO2UBIlcvc4JBdTos2vHeUhCop_KaoHPlkEXxF28SHSEWkU3ZUFstIZ9_viL1O718mj-ns-eFpcjdLnVSqTU2JykOeSUQvRS5Aap2BkcI4EAoJdSmN0FpLRd5wU2riAvMSytwoZzAbsev97rqpPzqKrV2F6Gi5LCqqu2g5okGujBI9vfpD53XXVP11Xwo0gIJe3eyVa-oYGyrtugmrotlaDnZXzi6C3ZWzRvX44nuye1uR_6U_qXog94D6BptAjY0u0K5XaMi11tfhv91PcDh12A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1558070060</pqid></control><display><type>article</type><title>Fatigue in advanced kidney disease</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Artom, Micol ; Moss-Morris, Rona ; Caskey, Fergus ; Chilcot, Joseph</creator><creatorcontrib>Artom, Micol ; Moss-Morris, Rona ; Caskey, Fergus ; Chilcot, Joseph</creatorcontrib><description>Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1038/ki.2014.86</identifier><identifier>PMID: 24694985</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age Factors ; chronic kidney disease ; Comorbidity ; Cytokines - blood ; Depression - psychology ; end-stage renal disease ; fatigue ; Fatigue - blood ; Fatigue - epidemiology ; Fatigue - etiology ; Fatigue - psychology ; Fatigue - therapy ; Humans ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - therapy ; Severity of Illness Index ; Sex Factors ; symptoms ; transplantation ; treatment</subject><ispartof>Kidney international, 2014-09, Vol.86 (3), p.497-505</ispartof><rights>2014 International Society of Nephrology</rights><rights>Copyright Nature Publishing Group Sep 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-8f56d093455d42920477308428c0265e57f48277746ed818f7e1259f0f986c853</citedby><cites>FETCH-LOGICAL-c466t-8f56d093455d42920477308428c0265e57f48277746ed818f7e1259f0f986c853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1558070060?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24694985$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Artom, Micol</creatorcontrib><creatorcontrib>Moss-Morris, Rona</creatorcontrib><creatorcontrib>Caskey, Fergus</creatorcontrib><creatorcontrib>Chilcot, Joseph</creatorcontrib><title>Fatigue in advanced kidney disease</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting.</description><subject>Age Factors</subject><subject>chronic kidney disease</subject><subject>Comorbidity</subject><subject>Cytokines - blood</subject><subject>Depression - psychology</subject><subject>end-stage renal disease</subject><subject>fatigue</subject><subject>Fatigue - blood</subject><subject>Fatigue - epidemiology</subject><subject>Fatigue - etiology</subject><subject>Fatigue - psychology</subject><subject>Fatigue - therapy</subject><subject>Humans</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - therapy</subject><subject>Severity of Illness Index</subject><subject>Sex Factors</subject><subject>symptoms</subject><subject>transplantation</subject><subject>treatment</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpt0E9LwzAYx_EgipvTiy9Ail5E6HyS5knSowynwsCLnkNNnkr2p51NO9i7t3PqQTyFwIcfD1_GzjmMOWTmdhHGArgcG3XAhhxFlnKNeMiGAAZTgZkZsJMY59D_8wyO2UBIlcvc4JBdTos2vHeUhCop_KaoHPlkEXxF28SHSEWkU3ZUFstIZ9_viL1O718mj-ns-eFpcjdLnVSqTU2JykOeSUQvRS5Aap2BkcI4EAoJdSmN0FpLRd5wU2riAvMSytwoZzAbsev97rqpPzqKrV2F6Gi5LCqqu2g5okGujBI9vfpD53XXVP11Xwo0gIJe3eyVa-oYGyrtugmrotlaDnZXzi6C3ZWzRvX44nuye1uR_6U_qXog94D6BptAjY0u0K5XaMi11tfhv91PcDh12A</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>Artom, Micol</creator><creator>Moss-Morris, Rona</creator><creator>Caskey, Fergus</creator><creator>Chilcot, Joseph</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20140901</creationdate><title>Fatigue in advanced kidney disease</title><author>Artom, Micol ; Moss-Morris, Rona ; Caskey, Fergus ; Chilcot, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-8f56d093455d42920477308428c0265e57f48277746ed818f7e1259f0f986c853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Age Factors</topic><topic>chronic kidney disease</topic><topic>Comorbidity</topic><topic>Cytokines - blood</topic><topic>Depression - psychology</topic><topic>end-stage renal disease</topic><topic>fatigue</topic><topic>Fatigue - blood</topic><topic>Fatigue - epidemiology</topic><topic>Fatigue - etiology</topic><topic>Fatigue - psychology</topic><topic>Fatigue - therapy</topic><topic>Humans</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - therapy</topic><topic>Severity of Illness Index</topic><topic>Sex Factors</topic><topic>symptoms</topic><topic>transplantation</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Artom, Micol</creatorcontrib><creatorcontrib>Moss-Morris, Rona</creatorcontrib><creatorcontrib>Caskey, Fergus</creatorcontrib><creatorcontrib>Chilcot, Joseph</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Artom, Micol</au><au>Moss-Morris, Rona</au><au>Caskey, Fergus</au><au>Chilcot, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fatigue in advanced kidney disease</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>86</volume><issue>3</issue><spage>497</spage><epage>505</epage><pages>497-505</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>Fatigue is commonly experienced in patients with advanced kidney disease and associated with poor outcomes. The prevalence of fatigue ranges from 42% to as high as 89% according to treatment modality and the measurement instruments used. This paper reviews studies examining sociodemographic, biological, and psychological factors associated with fatigue in advanced kidney disease. The association between fatigue and psychological factors, such as depression and anxiety, behavioral factors, such as sleep and nutrition, and cytokines, such as IL-6 and CRP corroborates the view of fatigue as a multidimensional and multifactorial problem. Although depression and fatigue are related, the relationship is typically moderate in size, thus fatigue should not simply be seen as a symptom of distress. Accordingly, it is important for treatment plans to address the complex etiology of fatigue through pharmacological and nonpharmacological interventions. To date, results of nonpharmacological interventions are promising, with physical exercise and cognitive-behavioral therapy showing beneficial results. Work conducted in other patient populations highlights the importance of cognitions and behaviors in the prediction and maintenance of fatigue. Such work could be applied to advanced kidney disease allowing a model of fatigue to be developed from which to base suitable interventions in this setting.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24694985</pmid><doi>10.1038/ki.2014.86</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0085-2538 |
ispartof | Kidney international, 2014-09, Vol.86 (3), p.497-505 |
issn | 0085-2538 1523-1755 |
language | eng |
recordid | cdi_proquest_miscellaneous_1558516862 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection |
subjects | Age Factors chronic kidney disease Comorbidity Cytokines - blood Depression - psychology end-stage renal disease fatigue Fatigue - blood Fatigue - epidemiology Fatigue - etiology Fatigue - psychology Fatigue - therapy Humans Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - therapy Severity of Illness Index Sex Factors symptoms transplantation treatment |
title | Fatigue in advanced kidney disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T16%3A00%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fatigue%20in%20advanced%20kidney%20disease&rft.jtitle=Kidney%20international&rft.au=Artom,%20Micol&rft.date=2014-09-01&rft.volume=86&rft.issue=3&rft.spage=497&rft.epage=505&rft.pages=497-505&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1038/ki.2014.86&rft_dat=%3Cproquest_cross%3E1558516862%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1558070060&rft_id=info:pmid/24694985&rft_els_id=S0085253815303318&rfr_iscdi=true |